Virtus Medical acquired International Medical Center – Beijing

HONG KONG SAR – Media
OutReach – 19 August 2021 – Virtus Medical Group (Virtus) is
pleased to announce that the Group has acquired 70% equity interests in International
Medical Center – Beijing (IMC). The acquisition demonstrates Virtus’s
commitment to delivering high-quality private healthcare and telemedicine
service across Beijing and its neighbouring cities. Acquisition of the remaining
30% equity interests is expected to be completed within 12 months.

IMC
is conveniently located in the heart of Beijing’s diplomatic and business
district, Lufthansa Business Circle, where many foreign embassies and multinational
corporations have their headquarters. Established in the early 90s, IMC was among
the first group of high-end medical institutions to serve foreigners. It
provides a wide variety of medical services, including Preventive Care, Primary
Care, Obstetrics & Gynaecology, Women’s Health, Paediatrics, Paediatric
Surgery, Stomatology, Dermatology, Emergency Medicine, Psychiatry, medical
examination, medical imaging and Traditional Chinese Medicine. With the support
of Beijing’s highest grade (AAA) hospitals, IMC provides one-stop services from
screening, diagnosis and treatment to rehabilitation to local residents as well
as people moving from Hong Kong, Macao, Taiwan and other countries to Beijing.
In addition, IMC has been actively expanding the network of overseas partners,
providing second medical opinions from international medical experts, and
arranging overseas medical examinations and treatments.  Its exemplary one-stop medical service model
and medical resources have been well recognized, as evidenced by “The Best
Hospital and Clinic Achievement Award” granted by Global Times in 2017.

Benefits
of China-Hong Kong Cooperation

The
prosperous development of personalized precision medicine, differences in
medical systems, verbal communication and different personal experiences all
make patients have higher requirements for medical services. The impact of
geographical restrictions is even more significant in the post-epidemic era. Dr
Manson Fok, Chairman of Virtus Medical Group, is confident that the acquisition
will achieve synergies that allow IMC to develop more green channels for
domestic referrals, relying on Virtus’s experience in developing diversified
high-end medical services and IMC’s mature service packages. Samuel Poon, CEO
of Virtus Medical Group,
believes that IMC can leverage the advanced knowledge, expertise, technology,
and professional ethics of the Hong Kong medical industry to boost patients’
confidence about Mainland China healthcare services.

Hong
Kong residents living in Beijing will benefit

On
the other hand, a robust multidisciplinary specialist team from Virtus is
preparing to provide IMC patients with telemedicine services. Telemedicine
service benefits patients who need a second opinion from medical experts and facilitates
medical knowledge exchange between Beijing and Hong Kong. More than 30
specialists are ready, covering Internal Medicine, Paediatrics, Paediatric Immunology,
Allergy & Infectious Diseases, Metabolism and Genetics, Paediatric
Respiratory Medicine, Paediatric Surgery, Paediatric Endocrinology,
Metabolism and Genetics, Cardiology, Neurology, Otorhinolaryngology, Gastroenterology
& Hepatology, Orthopaedics & Traumatology, Nephrology, Respiratory Medicine,
Clinical Oncology, Haematology & Haematological Oncology, Surgery,
Cardiothoracic Surgery, Neurosurgery and Urology. The telemedicine service overcomes
geographical and speech barriers and increases access to quality healthcare
services. It is expected to benefit more than tens of thousands of Hong Kong
residents living in Beijing.